J. Turner

Autoproliferation in HIV‐1‐infected patients undergoing active HIV‐1‐specific immunotherapy

F. Jensen, D. Carlo, R. Trauger, 1995, Clinical and experimental immunology.

Early clinical markers and CD4 percentage in subjects with human immunodeficiency virus infection.

R. Moss, D. Carlo, M. Wallace, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Use of HIV-1 pol gene precursor to detect HIV-1 and HIV-2

Yu-wen Hu, C. Kang, K. Reagan, 1990, The Lancet.

Effect of immunization with an inactivated gp120-depleted HIV-1 immunogen on beta-chemokine and cytokine production in subjects with HIV-1 infection.

R. Moss, F. Jensen, D. Carlo, 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

HIV‐1 immunogen induction of HIV‐1-specific delayed‐type hypersensitivity: results of a double‐blind, adjuvant‐controlled, dose‐ranging trial

D. Carlo, R. Trauger, A. Daigle, 1994, AIDS.

Human Immunodeficiency Virus (HIV) Infection and Quality of Life: The Potential Impact of Axis I Psychiatric Disorders in a Sample of 95 HIV Seropositive Men

C. Hutelmyer, W. Holmes, B. Bix, 1997, Psychosomatic medicine.

Viral load, CD4 percentage, and delayed-type hypersensitivity in subjects receiving the HIY-1 Immunogen and antiviral drug therapy

R. Moss, F. Jensen, D. Carlo, 1996, Journal of Clinical Immunology.

Antibodies against AIDS proteins

M. Parrington, C. Kang, K. Reagan, 1990, Nature.